Table 3.
Coronary Reactivity Testing and Coronary Severity Stenosis Score in Women with Coronary Flow Reserve Performed
| Invasive measures (Definition of Normal) | N | No APO | History of APO | p |
|---|---|---|---|---|
| CFR (≥2.5) | 185 | 2.76 ± 0.61, n = 146 | 2.53 ± 0.43, n = 39 | 0.016 |
| ΔCBF (>50% increase) | 152 | 67.67 ± 91.62, n = 118 | 46.77 ± 60.30, n = 34 | 0.475 |
| ΔACH (>0% increase) | 165 | −1.46 ± 13.44, n = 130 | −0.78 ± 16.15, n = 35 | 0.316 |
| ΔNTG (>20% increase) | 165 | 14.63 ± 13.74, n = 130 | 12.63 ± 10.92, n = 35 | 0.428 |
| Coronary severity stenosis score | 161 | 10.2 ± 4.07, n = 128 | 9.80 ± 4.34, n = 33 | 0.462 |
ΔACH, % diameter change in response to acetylcholine; ΔCBF, % coronary blood flow change in response to acetylcholine; CFR, coronary flow reserve in response to adenosine; ΔNTG, % diameter change in response to nitroglycerin.